Streetbeat News

Analyst Ratings

UBX

Wedbush analyst Andreas Argyrides has upgraded Unity Biotechnology (NASDAQ:UBX) from Neutral to Outperform, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 1:03 pm

LRN

Morgan Stanley analyst Greg Parrish has maintained an Equal-Weight rating on Stride Inc. (NYSE:LRN) and increased the price target from $57 to $60.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 1:02 pm

CTLT

Over the past quarter, Catalent (NYSE:CTLT) received 9 analyst ratings, with an average 12-month price target of $55.00, ranging from $46.00 to $62.00. The ratings included 2 bullish, 4 somewhat bullish, 2 indifferent, and 1 somewhat bearish. The average price target has risen by 13.57% in the past month. Analysts provide ratings based on financial analysis and company insights, and these ratings are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 1:00 pm

MAXN

Over the past 3 months, 9 analysts have published their opinions on Maxeon Solar Technologies (NASDAQ:MAXN), with an average 12-month price target of $16.33, a high of $25.00, and a low of $10.00. The current average price target represents a 39.52% decrease from the previous target of $27.00. Ratings are mixed, with 4 analysts bullish or somewhat bullish, 5 indifferent, and none bearish.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 1:00 pm

FISV

Fiserv (NYSE: FISV) has received various analyst ratings over the last quarter, with 1 bullish, 3 somewhat bullish, and 2 indifferent. The average 12-month price target among 6 analysts is $143.5, with a high of $175.00 and a low of $120.00. This target has increased by 1.06% from the previous target of $142.00. Analyst ratings are updated quarterly and can influence investor decisions.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 1:00 pm

DFS

Discover Financial Services (NYSE:DFS) received 14 analyst ratings in the last quarter, with 2 bullish, 3 somewhat bullish, and 9 indifferent. No bearish or somewhat bearish ratings were given. The average 12-month price target for DFS is $99.5, with a high of $109.00 and a low of $93.00. This target is a 6.62% decrease from the previous target of $106.55. Analyst ratings are updated quarterly and are based on financial statements, meetings, and insider information.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 1:00 pm

PM

Over the last 3 months, 7 Wall Street analysts have provided ratings for Philip Morris Intl (NYSE:PM), with an average 12-month price target of $107.14, a decrease from the previous target of $114.60. The ratings include 4 bullish, 2 somewhat bullish, and 1 indifferent. No bearish ratings were given. The high price target is $114.00 and the low is $95.00.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 1:00 pm

NVST

Envista Holdings (NYSE:NVST) has received 7 analyst ratings in the last quarter, with 2 bullish, 4 somewhat bullish, and 1 indifferent. The average 12-month price target among these analysts is $34.29, with a high of $42.00 and a low of $25.00. This target represents a 20.26% decrease from the previous target of $43.00. Analysts rate stocks based on research, financial statements, and insider communications, typically once per quarter.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 1:00 pm

SONO

Morgan Stanley analyst Erik Woodring has maintained an Equal-Weight rating on Sonos (NASDAQ:SONO) but reduced the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:56 pm

PETS

Morgan Stanley analyst Erin Wright has maintained an Underweight rating on PetMed Express (NASDAQ:PETS) and reduced the price target from $7 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:55 pm